Issn Print: 0269-2813
Publication Date: 2018/02/01
Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class?
H. H. Tsai
Author Information: Hull York Medical School and Hull and East Yorkshire NHS Trust
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.